Lilly Prozac Weekly
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Once-weekly formulation of fluoxetine receives "approvable" status from FDA Jan. 8. The standard formulation of Prozac will face generic competition after Aug. 2 unless Lilly wins its appeal of a patent rulin